Previous close | 47.84 |
Open | 47.84 |
Bid | 47.40 x 300 |
Ask | 47.44 x 500 |
Day's range | 47.22 - 48.02 |
52-week range | 39.48 - 52.81 |
Volume | |
Avg. volume | 2,427,581 |
Market cap | 14.11B |
Beta (5Y monthly) | 0.17 |
PE ratio (TTM) | 25.08 |
EPS (TTM) | 1.89 |
Earnings date | 04 Dec 2024 - 09 Dec 2024 |
Forward dividend & yield | 1.48 (3.12%) |
Ex-dividend date | 03 Oct 2024 |
1y target est | 51.43 |
CPB has shown resilience through its strategic execution and focus on innovation while facing challenges related to a volatile consumer environment.
Lower inflation means less top-line growth from price hikes, and sales volume is under pressure as consumers are more selective.
Investing.com -- As signs emerge that demand for GLP-1 drugs is stronger than expected, many are fearing the worst for packaged-food companies, but Bernstein believes that some companies are likely to fare better than others as patients on these weight-loss drugs shift appetite in favor of more protein-based foods.